Efficacy of tacrolimus in ABO-incompatible kidney transplantation: Clinicopathological aspect of humoral rejection

Transplantation Proceedings

Volumn 31, Issue 7, 1999, Pages 2851-2852

  Saito, K ^a   Nakagawa, Y ^a   Tanikawa, T ^a   Sonda, K ^a,c   Nishi, S ^a   Yamaguchi, Y ^a,b   Arakawa, M ^a   Takahashi, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Shiraishi Corp   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; LYMPHOCYTE ANTIBODY; OKT 3; TACROLIMUS;

ADULT; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SURVIVAL RATE;

ABO BLOOD-GROUP SYSTEM; ADULT; ANTIBODY FORMATION; BLOOD GROUP INCOMPATIBILITY; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; PLASMAPHERESIS; SURVIVAL ANALYSIS;

EID: 0032718094     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00588-6     Document Type: Conference Paper

References (2)

1. Takahashi K., Saito K., Sonda K., et al. Transplant Proc. 30:1998;1219.
2. Takahashi K. Acta Med Biol. 45:1997;95.